Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
<h4>Background</h4>In 2017, an estimated 14 million cases of Plasmodium vivax malaria were reported from Asia, Central and South America, and the Horn of Africa. The clinical burden of vivax malaria is largely driven by its ability to form dormant liver stages (hypnozoites) that can reac...
Saved in:
| Main Authors: | Angela Devine, Katherine E Battle, Niamh Meagher, Rosalind E Howes, Saber Dini, Peter W Gething, Julie A Simpson, Ric N Price, Yoel Lubell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-06-01
|
| Series: | PLoS Medicine |
| Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003614&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
by: Walter R J Taylor, et al.
Published: (2023-09-01) -
A long neglected world malaria map: Plasmodium vivax endemicity in 2010.
by: Peter W Gething, et al.
Published: (2012-01-01) -
Plasmodium vivax Transmission in Africa.
by: Rosalind E Howes, et al.
Published: (2015-11-01) -
Co-design of a routine clinical review to improve the safety of high dose radical cure treatment for Plasmodium vivax malaria: findings from Cambodia and Ethiopia
by: Sarah A. Cassidy-Seyoum, et al.
Published: (2025-05-01) -
An analytical method for assessing stage-specific drug activity in Plasmodium vivax malaria: implications for ex vivo drug susceptibility testing.
by: Douglas H Kerlin, et al.
Published: (2012-01-01)